MBD2-Mediated Transcriptional Repression of the p14ARF Tumor Suppressor Gene in Human Colon Cancer Cells

Objective: The p14ARF and p16INK4A tumor suppressor genes are commonly inactivated by aberrant methylation of their promoter regions in human colon cancer. The methyl-CpG-binding domain protein MBD2 is physically associated with the methylated promoters of the p14ARF and p16INK4A genes in specific tumor cell lines. Moreover, deficiency of MBD2 strongly inhibits intestinal tumorigenesis in the Min mouse, raising the possibility that the protein might be involved in transcriptional repression of methylated tumor suppressor genes. The aim of this study was to evaluate the role of MBD2 in the silencing of p14ARF and p16INK4A in cancer. Methods: The MBD2 protein was stably knocked down by RNA interference in RKO, a colon cancer cell line in which both p14ARF and p16INK4A are silenced by methylation. Results: We demonstrate here that MBD2 associates with the methylated promoter of the p14ARF gene in the RKO colon cancer cell line. Depletion of MBD2 by RNAi leads to selective upregulation of the p14ARF but not the p16INK4A gene transcript. In addition, p14ARF repression can be restored by expressing mouse MBD2 protein in MBD2-deficient RKO cells. Conclusion: These findings implicate MBD2 in transcriptional repression of the methylated p14ARF tumor suppressor gene and suggest that repression by MBD2 selectively affects a subset of methylated promoters.

[1]  K. Pantel,et al.  Methyl-CpG Binding Domain Proteins and Their Involvement in the Regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 Gene Promoters , 2007, Molecular Cancer Research.

[2]  Hideyuki Suzuki,et al.  RET finger protein enhances MBD2- and MBD4-dependent transcriptional repression. , 2006, Biochemical and biophysical research communications.

[3]  S. Nakielny,et al.  Control of the DNA Methylation System Component MBD2 by Protein Arginine Methylation , 2006, Molecular and Cellular Biology.

[4]  M. Szyf,et al.  Alteration of the methylation status of tumor-promoting genes decreases prostate cancer cell invasiveness and tumorigenesis in vitro and in vivo. , 2006, Cancer research.

[5]  J. S. Rao,et al.  CpG island promoter methylation and silencing of 14-3-3σ gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2 , 2006, Oncogene.

[6]  A. Bird,et al.  Genomic DNA methylation: the mark and its mediators. , 2006, Trends in biochemical sciences.

[7]  A. Bird,et al.  DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. , 2005, Molecular cell.

[8]  F. Magdinier,et al.  Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus , 2005, Nucleic acids research.

[9]  A. Horii,et al.  The Thymine DNA Glycosylase MBD4 Represses Transcription and Is Associated with Methylated p16INK4a and hMLH1 Genes , 2005, Molecular and Cellular Biology.

[10]  M. Sekimata,et al.  Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF. , 2004, Nucleic acids research.

[11]  M. Szyf,et al.  Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo. , 2003, Carcinogenesis.

[12]  A. Bird,et al.  Deficiency of Mbd2 suppresses intestinal tumorigenesis , 2003, Nature Genetics.

[13]  Esteban Ballestar,et al.  The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. , 2003, Nucleic acids research.

[14]  W. Nelson,et al.  Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. , 2003, Cancer research.

[15]  M. Szyf,et al.  Promoter-specific Activation and Demethylation by MBD2/Demethylase* , 2002, The Journal of Biological Chemistry.

[16]  E. Prokhortchouk,et al.  Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs? , 2002, Oncogene.

[17]  B. Göttgens,et al.  Establishing the transcriptional programme for blood: the SCL stem cell enhancer is regulated by a multiprotein complex containing Ets and GATA factors , 2002, The EMBO journal.

[18]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[19]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[20]  P. Jones,et al.  Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. , 2001, Nucleic acids research.

[21]  A. Wolffe,et al.  Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[23]  F. Bosman,et al.  Methylation Silencing and Mutations of the p14ARF and p16INK4a Genes in Colon Cancer , 2001, Laboratory Investigation.

[24]  Paul Tempst,et al.  MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex , 1999, Nature Genetics.

[25]  J. Herman,et al.  Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer , 1999, Nature Genetics.

[26]  L. Guillou,et al.  Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors. , 1997, The American journal of pathology.

[27]  C. D. Edwards,et al.  A novel p16INK4A transcript. , 1995, Cancer research.

[28]  A. Bird,et al.  Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. , 1992, Nucleic acids research.